Corporate Gender Ideology Has Borders After All

Greg Scott

October 20, 2026

“Pride has no borders.”

That was the slogan. Then the map showed up.

In June 2022, Amazon told American consumers it was going to “Pride Out Loud.” The same month, Amazon.ae hid more than 150 search terms in the United Arab Emirates (UAE) — among them “LGBTQ,” “Pride,” and “transgender flag.” Even so, the company said it remained committed to the cause.

The usual defense writes itself: different markets, different audiences, different campaigns. That is what the marketing department says when it wants credit for a conviction it can’t carry through customs.

Ordinary localization changes a menu, clothing colors, or a commercial. The difference is that these companies are changing the moral script they demand that American employees, customers and shareholders treat as non-negotiable. In the U.S. the script is a cause. In the Gulf, it is a liability. A cause you will not own anywhere on the map is not a cause. It is a costume.

The pattern is not subtle. And Amazon is not a one-off.

The full article can be read in Daily Caller.

Related Insights

Insights

Corporate Support for A4TE: Ideological Activism and Reputational Risk

LGBTQ+ Protecting Children

October 19, 2026

Advocates for Trans Equality (A4TE) is a radical organization promoting transgender ideology in law and policy in the United States. Formed in 2024 through the merger of the National Center for Transgender Equality (NCTE) and the Transgender Legal Defense and Education Fund (TLDEF), A4TE engages in public policy advocacy, impact litigation, political activity, research and data collection, and community organizing to advance its objectives. A4TE has actively opposed federal and state legislation seeking to restrict transition-related medical interventions for minors. Including, organizing a coalition of more than 160 national and grassroots organizations that urged Congress to reject H.R. 3492, legislation which sought to establish federal criminal penalties for providing certain transition-related procedures to minors. A4TE characterized the targeted treatments as “safe and evidence-based” health care and argued that restrictions would interfere with medical decision-making. A4TE references WPATH’s Standards of Care in support of transition-related medical care, despite the guidelines facing federal legal scrutiny. In June 2026, the FTC and four states sued WPATH, alleging misleading claims about the safety, effectiveness, and medical necessity of certain pediatric interventions. Major corporations, including Apple, Amazon, Google, and Disney, have been identified as corporate partners of A4TE. Through these partnerships, companies may receive opportunities to …

Insights

Podcast

Corporate stewardship, the cost of ideological activism, and the trust that built America.

Benevity CEI DEI ESG HRC LGBTQ+ Protecting Children SPLC

October 13, 2026

In this episode of The WallBuilders Show, Doug Napier, Executive Chairman and CEO of 1792 Exchange, joined host Rick Green to discuss The American Company, 1792 Exchange’s new effort to define and celebrate companies that act American. The conversation explores what separates a patriotic company from one that only waves the flag, and how Americans can help recognize the companies doing it right. Key Topics Discussed:

Insights

Op-Ed

Accenture said it ditched DEI. The DOJ just caught them running secret race scorecards

DEI

October 9, 2026

Color-coded monthly dashboards. Separate promotion conversations for candidates who moved demographic numbers in the “right” direction. Leadership programs with the door closed to the “wrong” race or sex. These are just a few of the flashing indicators that companies who should have known better had nonetheless embraced illegal employment practices. The avoidable result was the payment of huge fines. IBM paid $17 million. Deloitte paid $21.5 million. Now Accenture agreed to pay $25 million to resolve Justice Department allegations that it did the same things, while certifying it did not in order to continue its collection of big bucks from taxpayers. Three of the largest consulting firms — companies selling “expert” advice to government and Fortune 500 clients on workplace “transformation” — have written checks totaling $63.5 million in a single year under the Civil Rights Fraud Initiative. That’s a pattern. And a problem. The DOJ alleged that since 2017, Accenture Federal Services treated race and sex as factors in hiring and promotions to hit “stealth” workforce composition goals. Business-unit leaders received monthly summaries of the exact percentage of each race and sex in their units, highlighted to show if they were on target. Those scorecards drove improper hiring decisions, …

Insights

Op-Ed

Your Company’s Charity List May Have a Political Screen Built in

Benevity SPLC

September 30, 2026

Millions of workers in America donate to charities through giving portals set up by their employers, confident that a full range of legitimate nonprofits is just a few clicks away. But this trust, unfortunately, is often misplaced. Many companies turn to third-party platforms such as Benevity, Bonterra and Groundswell to operate their charitable-giving programs. Benevity is the largest of these, processing billions of dollars in donations annually. Though it does not publish a full list of its clients, research by my organization, 1792 Exchange, has identified more than 200 Fortune 1000 companies with Benevity portals, representing millions of employees. Part of the appeal of these services is that experts have done the vetting work. So employees who use them to make donations reasonably assume that if a charity is excluded, it failed some objective test of legal compliance, financial transparency or organizational integrity. In the case of Benevity, however, that assumption is often incorrect. And the problem is not that companies outsource the work of vetting nonprofits to Benevity. The problem is in the process used to decide which organizations to include and which to leave out. The full article can be found in The Washington Post.

Insights

Referenced

The Companies That Left HRC’s Index Are Still Sponsoring Gender Ideology

CEI HRC LGBTQ+

September 29, 2026

Several major corporations that publicly stepped back from DEI programs and the Human Rights Campaign’s Corporate Equality Index may not have retreated as far as headlines suggested. A new Blaze Media report, drawing on 1792 Exchange’s tracking, finds that Ford, Molson Coors, Target, and T-Mobile continued to bankroll LGBT activist events in 2026 even after signaling reform. The piece uses 1792 Exchange’s work on corporate DEI commitments, CEI participation, and ideological nonbusiness activities to show the gap between what these companies announced and what they still fund. Each of the four had signaled a change: Ford (2024) and Molson Coors (2024) said they would exit the CEI, and Target (2025) and T-Mobile (2025) announced they were ending DEI initiatives and index participation. Yet in 2026, Target was listed as a platinum sponsor of NYC Pride — whose youth programming included a rally “to demand protections for trans and queer youth” — along with Pride events in Los Angeles, Houston, San Francisco, Salt Lake City, and New Jersey. Molson Coors, through its Vizzy brand, sponsored Pride events in Miami Beach, Denver, and New Jersey; T-Mobile backed Pride events in Phoenix, Des Moines, and Philadelphia. Children appear to have been present at …

Insights

Referenced

Inspire Investing Maps the Four-Year Reversal on Gender-Transition Care for Minors

CEI HRC LGBTQ+ Protecting Children

September 22, 2026

On August 11, 2026, the Centers for Medicare & Medicaid Services issued a first-of-its-kind final rule barring federal Medicaid and CHIP dollars from covering puberty blockers, cross-sex hormones, or surgeries for minors, effective October 13, 2026. A new analysis from Inspire Investing frames the rule as the capstone of a four-year reversal across American law, medicine, and corporate benefit plans. The piece, by Chris Hubbard with Tim Schwarzenberger, traces how a once-expanding consensus fractured, in the courts, in the medical literature, in Europe, and in corporate boardrooms, and why values-driven investors are now pressing companies on the issue. The Supreme Court’s June 2025 ruling in United States v. Skrmetti upheld state limits, leaving bans in roughly 27 states in force. A May 2025 HHS evidence review found the certainty of benefit “very low,” echoing England’s Cass Review. Corporate participation in the Human Rights Campaign’s Corporate Equality Index fell 65% in a single year, from 377 Fortune 500 companies to 131. 1792 Exchange has named 550-plus companies whose plans still cover these procedures for minor dependents and wrote to 568 companies in June urging them to exclude transgender drugs and surgeries for children. Inspire organized a coalition representing more than $100 …